Loading clinical trials...
Loading clinical trials...
The Immunogenicity and Safety of Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib
Conditions
Interventions
SHINGRIX
Locations
1
United States
Boston Medical Center
Boston, Massachusetts, United States
Start Date
July 31, 2019
Primary Completion Date
July 4, 2024
Completion Date
July 4, 2024
Last Updated
February 21, 2025
NCT06226883
NCT05986136
NCT06573723
NCT06579443
NCT07033208
NCT05733702
Lead Sponsor
Boston Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions